Showing results (1-10 of 416) with videos related to
Sort By:
Pageof 42
Rheumatology (Oxford, England)|April 12, 2026
Novel glucocorticoids: current status and challengesFrank Buttgereit, Christopher J EdwardsBulletin of the NYU Hospital for Joint Diseases|December 25, 2012
A fresh look at glucocorticoids how to use an old ally more effectivelyFrank ButtgereitNature Reviews. Rheumatology|February 21, 2020
Views on glucocorticoid therapy in rheumatology: the age of convergenceFrank ButtgereitSteroids|April 19, 2002
Rapid glucocorticoid effects on immune cellsFrank Buttgereit, Alexander ScheffoldNature Clinical Practice. Rheumatology|September 3, 2008
Genomic and nongenomic effects of glucocorticoidsCindy Stahn, Frank ButtgereitMolecular and Cellular Endocrinology|February 14, 2013
Optimized glucocorticoid therapy: teaching old drugs new tricksCindy Strehl, Frank ButtgereitJoint Bone Spine|October 3, 2021
How to taper glucocorticoids in inflammatory rheumatic diseases? A narrative review of novel evidence in rheumatoid arthritis, systemic lupus erythematosus, and giant cell arteritisFrank Buttgereit, Andriko PalmowskiRheumatology (Oxford, England)|April 16, 2013
A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritisMaarten Boers, Frank ButtgereitExpert Opinion on Pharmacotherapy|April 19, 2013
Delayed-release prednisone - a new approach to an old therapyFrank Buttgereit, Allan GibofskyCurrent Rheumatology Reports|October 13, 2020
Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel VasculitisAndriko Palmowski, Frank ButtgereitPageof 42